A randomized trial of low versus moderate exposure busulfan for infants with severe combined immunodeficiency (SCID) receiving TCR¿ss+/CD19+ depleted transplantation
Clinical Trial Grant
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
National Marrow Donor Program
Start Date
February 18, 2025
End Date
May 31, 2029
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
National Marrow Donor Program
Start Date
February 18, 2025
End Date
May 31, 2029